In June, Houston-based University of Texas MD Anderson Cancer Center earned its sixth Magnet designation and its first Magnet with Distinction rating from the American Nurses Credentialing Center. The ...

MD Anderson and TOPPAN Holdings announced a strategic alliance to co-develop TOPPAN Holdings' invivoid 3D cell culture technology as a tool for personalized cancer treatments and drug screening ...

Radiation therapy may account for half of all new cancers among the growing population of childhood cancer survivors, according to a study published Aug. 11 in the Journal of Clinical Oncology. With ...

In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back ...

The department’s technical rescue team worked to bring the woman down from an elevated location after she fell off a ladder ...

Texas, and they prove that Houston is in good hands.H-Town's esteemed Houston Methodist Hospital was rated the No. 1 best ...

Approval followed priority review and was based on response rates and duration of response demonstrated in the phase 1b ...

Despite 22 active research projects aimed at advancing mRNA vaccines against various diseases, Kennedy claims the technology ...

The department has built a long-standing academic partnership with Professor Laurence Court and his team at the MD Anderson ...

Houston hospitals named among best in U.S. News & World Report's 2025 rankings, including MD Anderson and Houston Methodist.

Once a symbol of triumph, the cancer bell can also trigger distress. Research and patient reports reveal its impact, inspiring more inclusive and personal ways to honor milestones.

The FDA on Friday granted accelerated approval to zongertinib (Hernexeos) for non-squamous non-small cell lung cancer (NSCLC) ...